In the PASER-M cohort representing six countries in sub-Saharan Africa, among patients with VLS, those with poor CD4 recovery (<200) demonstrated significantly higher rates of HIV-related mortality, incidence of AIDS and incidence of pulmonary TB for several years post-ART initiation [25]. This evidence concerns the gene CD4 and pulmonary tuberculosis.